A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France. File photo/Reuters
French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the ‘Tamiflu’ product in the United States.
The deal will give Sanofi exclusive US over-the-counter (OTC) rights to Tamiflu, which is used for the prevention and treatment of flu.
“This is a strategic and important transaction for us as we strive to continually bring innovations to the market,” said Alan Main, executive vice president of Sanofi’s consumer healthcare division, in a statement.
The European Union (EU) signed a landmark free trade deal with Vietnam on Sunday, the first of its kind with a developing country in Asia, paving the way for tariff reductions on 99% of goods between the trading bloc and Southeast Asian country.
South Africa’s Biovac Institute will start local production of Sanofi’s Hexaxim vaccine next year and Pfizer’s anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.
President Donald Trump on Thursday for the first time linked a dispute over telecom giant Huawei, which he views as a threat to American security, with a deal to resolve the US-China trade war.
Leaders of the Group of Seven wealthy nations discuss global trade woes on the second day of their annual summit on Sunday, likely laying bare a yawning divide between US President Donald Trump and his Western allies.
More than 64 million people will switch to vaping devices instead of smoking traditional cigarettes over the next three years according to expert forecasts, and Dubai is to provide a global platform for an industry expected to be worth $53.4 billion by 2024.
India’s central government gave a major boost to the automobile industry by announcing a slew of measures to reverse slowdown denting the sector.